About Us

ABOUT US

Amelia Technologies LLC is a rapidly expanding molecular biotechnology company with laboratories and offices located in the Maryland, DC, Virginia biotechnology corridor.

Amelia excels in the development and optimization of molecular diagnostics platforms that measure a range of endpoints associated with DNA damage and repair including general DNA maintenance processes. Currently, Amelia leverages this expertise in four major overlapping areas of research:

Carcinogenesis, aging and associated diseases, genome editing protocols and emerging diagnostics platforms.  Our clients and collaborators include academia, industry and government organizations both here in the United States and abroad.

Amelia-Technologies-lab-01

Amelia strives to provide a confidential platform in which new molecular technology can be further optimized, better developed or adapted to higher through-put detection. We also provide a range of skills and technology to our clients that allow them to more quickly conquer hurdles in methodology that are inhibiting timely development of product.